Bioactive properties and phenolic profile of Momordica charantia L. medicinal plant growing wild in Trinidad and Tobago

[Display omitted] •Crude extract of wild M. charantia revealed multiple biological activities.•Aerial parts are rich in quercetin glycosides and kaempferol glycosides.•Five phenolic compounds were described for the first time in M. charantia.•Inhibition of clinical bacterial isolates was observed.•R...

Full description

Saved in:
Bibliographic Details
Published inIndustrial crops and products Vol. 95; pp. 365 - 373
Main Authors Svobodova, Blanka, Barros, Lillian, Calhelha, Ricardo C., Heleno, Sandrina, Alves, Maria Jose, Walcott, Simone, Bittova, Miroslava, Kuban, Vlastimil, Ferreira, Isabel C.F.R.
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.01.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Display omitted] •Crude extract of wild M. charantia revealed multiple biological activities.•Aerial parts are rich in quercetin glycosides and kaempferol glycosides.•Five phenolic compounds were described for the first time in M. charantia.•Inhibition of clinical bacterial isolates was observed.•Reducing power and β-carotene bleaching assay results are comparable to trolox standard. A wild variety of bitter melon Momordica charantia L. (Cucurbitaceae) has been used in bush medicine of Trinidad and Tobago for treatment of diabetes, inflammations and cancer. Despite many studies regarding the cultivated bitter melon, the wild variety has been poorly investigated. This study evaluates the biological activities of the ethanol/water extract of aerial parts and correlates these activities with the presence of phenolic compounds. The extract exhibited antioxidant activity in the four assays (DPPH, reducing power, β-carotene bleaching and TBARS). The key role of oxidative stress in inflammation and tumorigenesis was supported by the results of anti-inflammatory (inhibition of nitric oxide production) and cytotoxicity (human tumor cell lines, namely HeLa, HepG2, MCF-7, and NCI-H460) assays. In contrast, no toxicity was observed in non-tumor cells. In the antibacterial screening, clinical resistant isolates were significantly affected (MIC50=10–0.625μg/mL), being Listeria monocytogenes the most susceptible. Three phenolic acids and eleven flavonol glycosides derivatives were identified, quercetin-3-O-pentosylhexoside being the most abundant.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0926-6690
1872-633X
DOI:10.1016/j.indcrop.2016.10.046